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Abstract
Background: Cardiovascular Magnetic Resonance is often used to evaluate patients after heart valve replacement. This
study systematically analyses the influence of heart valve prostheses on phase contrast measurements in a phantom trial.
Methods: Two biological and one mechanical aortic valve prostheses were integrated in a flow phantom. B0 maps and
phase contrast measurements were acquired at a 1.5 T MR scanner using conventional gradient-echo sequences in
predefined distances to the prostheses. Results were compared to measurements with a synthetic metal-free aortic valve.
Results: The flow results at the level of the prosthesis differed significantly from the reference flow acquired before the
level of the prosthesis. The maximum flow miscalculation was 154 ml/s for one of the biological prostheses and 140 ml/s
for the mechanical prosthesis. Measurements with the synthetic aortic valve did not show significant deviations. Flow
values measured approximately 20 mm distal to the level of the prosthesis agreed with the reference flow for all tested
all prostheses.
Conclusions: The tested heart valve prostheses lead to a significant deviation of the measured flow rates compared to a
reference. A distance of 20 mm was effective in our setting to avoid this influence.
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Background
Approximately 280.000 heart valve prostheses are im-
planted worldwide each year; approximately 50% of
them are mechanical and 50% bioprosthetic. Due to the
medical development and increasing life expectancy, the
number of surgeries and interventions is expected to rise
[1, 2]. Currently, surgical aortic valve replacement with
biological or mechanical prostheses is the standard of
care in most cases of aortic stenosis [3, 4]. In patients
with high risk to the surgical procedure, transcatheter
aortic valve implantation (TAVI) can be considered [3, 5,
6]. Most prostheses have metal compounds in varying
amounts and compositions [7].
After valve replacement, the evaluation of prosthetic
function and potential prosthesis-related complications is
essential [1, 6, 8]. The transthoracic echocardiography
(TTE) is the first-line modality for this assessment [9, 10],
but the validity of TTE may be limited due to the physical
condition of the patient, especially in a postoperative set-
ting. Furthermore, TTE is known to have a high observer
dependency [11–13]. Cardiovascular Magnetic Resonance
(CMR) is independent of the patient’s anatomy and less
observer dependent [13]. Flow measurement with phase
contrast (PC) sequences in CMR is used for evaluation
and quantification of heart valve disease; it is regarded as
robust and valid [11, 14, 15]. In biological valve pros-
theses, the direct assessment of the orifice area and the
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analysis of the flow pattern using CMR have already been
demonstrated [16–18].
In patients with heart valve prostheses, the metallic
compounds often evoke image artefacts, such as phase
alterations, image distortion, or even signal loss due to
the local distortion of the magnetic field [19].
The purpose of this study is to investigate, whether
metal-containing heart valve prostheses have influence
on PC based flow measurements.
Methods
The study was performed with a clinical 1.5 T MR sys-
tem (MAGNETOM Avanto, Siemens Healthcare GmbH,
Erlangen, Germany) equipped with a 6-channel body
array coil in combination with a spine array coil.
Phantom setup
We used a custom-built closed-circuit flow phantom
[20]. It consists of a semi-rigid tube system with a
pump generating adjustable constant flow and an
acrylic pipe resembling the dimensions of the native
aortic root. This acrylic pipe could hold different
prostheses. The system was filled with a mixture of
glycerol (40%) and water (60%) to approximate blood
viscosity and relaxation times.
The flow phantom was inserted in a water-filled con-
tainer. The acrylic pipe was placed in the coronal plane
45° oblique between the head-foot and left-right axes to
imitate the alignment of the ascending aorta in-vivo.
The setting is illustrated in Fig. 1.
To assess background phase errors, all imaging
slices were obtained with the phase contrast sequence
while the pump was switched off. To avoid unin-
tended flow in the water-filled container, we per-
formed the first scan after 15 min rest following each
table movement. Flow measurements in the phantom
were performed with the synthetic metal-free aortic
valve, the prosthesis I, II and III. Subsequently, the
measurements were repeated in the same order with
the pump switched on at fixed submaximal power.
The flow output varied due to the different orifice
areas of the valves.
Synthetic aortic valve
A 3D-printed aortic valve shaped synthetic inlay (Fig. 2)
served as the metal-free model. It approximated the
prostheses with an orifice area of about 2.0 cm2 (Table 1).
Flow measurements were compared between the metal-
free aortic valve model and the metal-containing pros-
theses to identify metal-related influences.
Prostheses
We investigated three metal-containing aortic valve
prostheses from different manufacturers (Fig. 2). Pros-
thetic sizes were chosen to yield similar orifice areas.
a b  c
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Fig. 1 Setting of the MR flow phantom for in-vitro assessment of heart valve prostheses. a. Scheme of the experimental setting showing the closed circuit
flow phantom as placed in the scanner. b. Scheme of the acrylic pipe and positioning of the measurement slices (S1-S12). c. Coronal magnitude image of
the acrylic pipe, proximal and distal parts of the tube system and positioning of the measurement slices. The arrow demonstrates the direction of flow
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Prostheses I and II are biological valve prostheses con-
sisting of bovine pericardium mounted on a stent. Pros-
thesis III is a mechanical bileaflet valve.
The details of material composition based on manufac-
ture’s data are listed in Table 1. All investigated prosthetic
types are in clinical use for surgical aortic valve replace-
ment and are regarded as MRI-conditional [10, 21–23].
In-vivo example
To illustrate the effect in vivo, we have added single
cases with identical types of aortic valve prostheses
and a healthy volunteer. Echocardiography was
performed within last 6 months and revealed an
adequate valve function as well as a non-dilated as-
cending aorta.
Additionally one healthy volunteer was scanned as an
in-vivo control reflecting the synthetic aortic valve of the
phantom trial.
The protocol was similar to the phantom study.
MR measurements
The following scan protocol was applied in all pros-
theses. Localizer scans were performed to locate the
aorta model. B0 maps were acquired in the coronal long
axis of the model. Flow measurements were performed
in 12 slices transversal to the flow direction.
B0 mapping
B0 maps in coronal planes were acquired in the ab-
sence of flow to reveal local magnetic field inhomo-
geneity. A multi-echo gradient echo sequence with a
total of 5 echoes was used. Sequence parameters
were: repetition time TR = 50.00 ms, echo time TE1 =
3.86 ms, TE2 = 9.12 ms, TE3 = 14.38 ms, TE4 =
19.64 ms, TE5 = 24.90 ms, slice thickness 5 mm +
1 mm gap, flip angle 15°, voxel size 2.0 × 2.0 ×
5.0 mm3.
B0 maps were computed using MatLab (The Math-
Works, Natick, MA, USA).
Quantitative B0 profile plots along the long axis of the
flow phantom were generated. Therefore, an intralum-
inal long axis slice was set through the level of the pros-
thesis (demonstrated in Fig. 3 top right).
To objectively assess the visual impressions from mag-
nitude images and B0 maps, we used a quantitative score
to describe the local magnetic field distortion. The score
was defined by quantifying the distortions of the local
magnetic field in Hertz (Hz) derived from the profile plots
seen in Fig. 3. Magnetic field distortions from B0 of less
than 50 Hz were graded as ‘none’, from 51 to 150 Hz as
‘mild’, 151 to 250 Hz as ‘moderate’ and more than 250 Hz
as ‘severe’.
PC flow measurement
A conventional segmented gradient-echo-based PC
cine sequence was applied. Sequence parameters were:
temporal resolution 47.7 ms, TE 2.3 ms, TR 5.9 ms,
slice thickness 5.5 mm + 1.1 mm gap, flip angle 30°,
inplane resolution 1.9 × 1.9 mm2, GRAPPA reduction
factor 2.
To maintain sequence parameters consistent through-
out the measurements, but also to avoid possible phase
a Synthetic aortic valve b Prosthesis I
c Prosthesis II d Prosthesis III
Fig. 2 Objects investigated in flow phantom. a. Metal-free aortic
valve shaped inlay, containing solely plastics. b. Biological aortic
valve prosthesis, containing metal-stent. c. Biological aortic valve
prosthesis, containing metal-stent. d. Mechanical aortic valve
prosthesis, containing carbon
Table 1 Detailed schedule of material components
Investigated
objects
Material components, percentage of metal elements,
orifice area
Synthetic
aortic valve
Acrylonitrile-Butadiene-Styrene copolymer (ABS plus),
3D printed
Orifice area: 2.0 cm2
Prosthesis I Stent: polyoxymethylene, covered with polyester cloth
Annulus: tungsten, silicon
Leaflet: glutaraldehyde fixated bovine pericardium
Orifice area: 2.0 cm2
Prosthesis II Stent: corrosion-resistant Elgiloy (cobalt 40%, chromium
20%, nickel 15%, molybdenum 7%, manganese 2%,
carbon <0.10%, beryllium <0.10%, iron 5.8%)
Leaflet: bovine pericadium
Orifice area: 1.8 cm2
Prosthesis III Orifice: pyrolythic carbon
Leaflets: pyrolytic carbon graphite coated and tungsten
(20%) impregnated
Annulus: pyrolytic carbon, velour polyester, titanium,
coated with Hemashield conduit (double velour
polyester collagen impregnated)
Orifice area: 1.55 cm2
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aliasing due to the different maximum flow velocities in
the prostheses, velocity encoding was set to 500 cm/s for
all measurements.
A 60-beats-per-minute ECG simulator was used as ac-
quisition trigger.
PC images were acquired at 12 positions: Slice 1 (S1)
was set perpendicular to the tube and 40 mm proximal
to the level of the prosthesis. This slice was defined as
reference flow level, where constant laminar flow was as-
sumed. S2 was set at the level of the prosthesis and was
a b c d
Fig. 3 Results of B0 mapping. a. Coronal images of B0 maps, coloured scale in Hertz. b. Corresponding profile plots showing the quantitative magnetic
field distortion from B0 in Hertz. c. Corresponding coronal magnitude images. White dashed line top right: Intraluminal positioning of slice for generating
profile plots in MATLAB. d. Description of the magnetic field distortions according to quantitative score
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positioned to the isocenter of the scanner. Ten more po-
sitions were defined (S3-S12) based on slice thickness
5.5 mm +1.1 mm gap distal to the level of the prosthesis
(see Fig. 1). S1 and S3 to 12 were not acquired in the
isocenter to avoid table movement and therefore fluid
motion in the water-basket.
Due to anatomical reasons we could not define a refer-
ence measurement point in-vivo similar to the phantom.
So the in-vivo measurements start at the area of the aor-
tic valve with slice 2 (S2) and amount 11 measurement
positions.
PC measurements were repeated three times per pos-
ition and flow results were averaged.
PC images were analysed using cvi42 Version 4.1.5
(Circle Cardiovascular Imaging, Calgary, Canada). Seg-
mentation of the tube was done in the magnitude image.
Contours were automatically propagated into all tem-
poral phases of the phase image and manually adapted if
necessary.
Statistical analysis
Calculations were performed using SAS 9.2 (SAS Insti-
tute Inc., Cary, NC, USA). Figures were prepared using
R Version 3.2.1 [24] with packages ggplot2 [25] and
RColorBrewer [26]. Least-square mean flow deviations
from reference flow were calculated along with 95% con-
fidence intervals (CI) in a statistical linear mixed model
with the flow at the reference level (S1) as co-factor. The
sensitivity analyses based on non-parametric models
supported the outcomes of the linear mixed model and
are not further displayed. Other factors were the dis-
tance and the type of prosthesis. Due to the small sam-
ple size, the statistical linear mixed model was repeated
based on ranks to account for any non-normality of the
data as sensitivity analysis to check for the robustness of
the assumption of normality. The flow deviations were
presented graphically per type of prosthesis. In addition,
the distance to the level of the prosthesis was displayed
along with equivalence limits of ±15% and ±20%. The
equivalence limits were calculated as mean flow at the
reference level ± the defined percentage limit of clinical
irrelevance. As no validated or established limit of
equivalence is published, two reasonable limits are re-
ported here.
Significance in this setting is defined as a deviation of
the flow values from reference flow (S1) of less than 15%
or 20% respectively (range of equivalence). Positions in
that range are described as significant, i.e. showed
equivalence referred to the reference flow. Conversely
no equivalence can be concluded for values out of this
range. Convergence of flow values is defined as mean
flow difference of less than 15% to reference flow and
nearly identical flow values beyond that distance.
Results
All PC image series were successfully acquired and
evaluable.
B0 mapping
The B0 maps in Fig. 3 demonstrate that depending on
the type of valve, the local magnetic field distortions var-
ied. In the synthetic aortic valve, no relevant distortion
was detected. In contrast, the B0 maps of the prostheses
showed moderate and severe distortions. The quantita-
tive aberration from B0 magnetic field as an expression
of distortion is shown in Fig. 4. It was 27 Hz in the syn-
thetic aortic valve, which was classified as not relevant
according to the score. In contrast, the aberration was
230 Hz in biological prosthesis I and 170 Hz in the
mechanical valve III, which were classified both as mod-
erate. In biological prosthesis II, the aberration was
280 Hz, which was classified as severe distortion.
PC flow measurement - flow phantom
As seen in Table 2 and Fig. 5, the synthetic aortic valve
showed a maximum absolute flow deviation over the
whole distance of 46 ml/s, corresponding to 15% of the
baseline flow. In bioprosthesis I, the flow deviation
amounted 88 ml/s, corresponding to 29% of the baseline
flow. Bioprosthesis II showed 154 ml/s flow deviation,
corresponding to 53% of the baseline flow. In the mech-
anical prosthesis, a flow deviation of 140 ml/s was ob-
served, corresponding to 35% of the baseline flow. There
was a convergence to baseline flow after 19.8 mm (3
slice distances) distal to the bioprosthesis I, in bioprosth-
esis II and the mechanical prosthesis after 13.2 mm (2
slice distances).
PC flow measurement - in-vivo example
As seen in Fig. 6b) the volunteer showed a maximum
absolute flow deviation over the whole distance of
around 18 ml/s with a maximum mean flow of 154 ml/s
in the area of the native aortic valve (S2 compared to
phantom) and a minimum mean flow of 136 ml/s
33 mm distal to the area of the aortic valve (S7 com-
pared to phantom).
In bioprosthesis I, the flow deviation amounted
28 ml/s with a maximum mean flow of 71 ml/s
13.2 mm distal to the area of the prosthesis (S4 com-
pared to phantom) and a minimum mean flow of
42 ml/s 59.4 mm distal to the area of the aortic valve
(S11 compared to phantom).
Bioprosthesis II showed 65 ml/s flow deviation with a
maximum mean flow of 123 ml/s in the area of pros-
thesis (S2 compared to phantom) and a minimum mean
flow of 59 ml/s 26.4 mm distal to the area of the aortic
valve (S6 compared to phantom).
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In the mechanical prosthesis III a flow deviation of
64 ml/s was observed with a maximum mean flow of
100 ml/s 6.6 mm distal to the prosthesis (S3 compared
to phantom) and a minimum mean flow of 37 ml/s in
the area of the prosthesis (S1 compared to phantom).
The flow volume curves of patient and flow phantom
are showing a similar shape as seen in Fig. 6. A
normalization of flow volume could be identified ap-
proximately 26 mm distal to the prostheses level in all
in-vivo tests. At this position no artefacts could be iden-
tified anymore in the corresponding anatomical images.
The biological valve prosthesis II showed the most se-
vere artefacts and flow miscalculation, which meets also
the result of the in-vitro trial. A comparison between in-
vivo cine imaging (Fig. 6c) and d)) and in-vitro magni-
tude pictures (Fig. 3) shows the accordance clearly.
Background offset error detection in the absence of flow
Statistical analyses of the range of equivalence were not
meaningful for the measurements without flow gener-
ated by the pump, as the reference flow values were too
low. In this case, significance is defined as a relevant de-
viation from zero flow in ml/s with a two-sided p-value
below or equal 0.05.
Flow measurements without flow revealed no differ-
ences between reference level and the slices distal to the
Table 2 Results of Phase contrast-based flow measurement
Synthetic aortic valve Prosthesis I Prosthesis II Prosthesis III
a. Peaks of flow deviation
(mean min/max) [ml/s]
5.28 (−4.92 to 15.48) at
S2 to −41.03 (−51.23 to
−30.83) at S7
55.47 (49.54 to 61.39)
at S4 to −32.41 (−38.34
to −26.49) at S8
132.20 (126.13 to 138.27)
at S2 to - 22.20 (− 28.27
to −16.13) at S5
119.13 (112.14 to 126.12)
at S3 to - 21.15 (− 28.14
to - 14.16) at S6
b. Absolute flow variation
[ml/s]
46 88 154 140
Percentage according to
baseline [%]
15 29 53 35
c. Significance within 15%
range of equivalence [ml/s]
all positions, except S7
+/−47.08
all positions, except S3
& S4 +/−44.91
all positions, except S2 & S3
+/−43.94
all positions, except S3
+/−32.20
Significance within 20%
range of equivalence [ml/s]
all positions
+/−62.77
all positions, except S4
+/−59.87
all positions, except S2 & S3
+/−58.59
all positions, except S3
+/−42.94
d. Convergence to reference
flow [mm]
19.8 (S5) 13.2 (S4) 13.2 (S4)
a. Min. & max. deviation of flow values from reference flow (S1) & their local attribution (peak to peak), 95% confidence interval bracketed
b. Absolute flow variation between the two peaks. Percentage of flow variation according to the absolute flow values at S1
c. Significances for all measured slices within two ranges of equivalence (15% and 20%)
d. Convergence of flow values: mean flow deviation of less than 15% to reference flow, nearly identical flow values beyond that distance
S1-12 = slice 1 to 12, positions of image acquisition in flow phantom
Fig. 4 Quantitative aberration from B0 magnetic field in all investigated objects. Deviation in Hertz (Hz) derived from B0 maps and profile plots.
Corresponding table showing positive and negative maximum of field aberration in Hz over the whole investigated distance. The numbers within
the bars indicate the absolute range of deviation in Hz, as it is used for the quantitative score
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prosthesis in all investigated objects. As depicted in
Fig. 7, there is no significant deviation of flow values
over the entire distance (p > 0.05), meaning no relevant
background offset errors.
Discussion
This phantom study investigated the influence of three
different metal containing heart valve prostheses on PC
flow measurements at 1.5 T. The main finding is that
the flow measurements were corrupted in the vicinity of
the tested valve prostheses. The extent of flow miscalcu-
lation depended on the composition of the prosthesis
and on the distance of the measurement slice to the
prosthesis. In contrast, PC measurements even in close
proximity to a synthetic metal-free aortic valve model or
a native aortic valve yielded nearly constant flow values.
PC measurements are expected to be B0-insensitive, as
two images containing the same flow-unrelated phase
errors are subtracted from each other [27]. In this study,
we could reproduce this finding in measurements where
no flow was present – notwithstanding all tested metal
containing prostheses markedly altered the local mag-
netic field. Beyond that, imaging and flow encoding gra-
dients induce eddy currents in the metal stent that
evoke superimposing local magnetic field distortions.
In case of no flow, i.e. the pump was switched off, it
could be shown that the phase contrast measurement
yielded a net phase of zero after subtraction of the flow-
compensated from the flow-encoded measurement even
in the presence of these additional local magnetic field
distortions.
In case of flow, however, the results showed that in the
proximity of the metal stented prostheses severe flow
measurement errors occurred. As for the static magnetic
field related distortions and the imaging gradients re-
lated distortions, the flow-encoded measurement and
the flow-compensated measurement experience identical
field alterations. However, as the flow-encoding gradient
scheme and the flow-compensating gradient scheme are
dissimilar, these gradient schemes also induce different
local and temporal magnetic field distortions. Analysis of
the B0 maps in the proximity of the heart valve pros-
theses revealed that the severity of local magnetic field
inhomogeneity was coincident with the severity of flow
miscalculations. Coherence between the extent of the
flow miscalculation and the material composition of the
prosthesis seems to be likely as different material com-
positions inherit different magnetic susceptibilities and
thus induce different magnetic field distortions. Analo-
gous to the fact that the interaction with more suscep-
tible material leads to stronger B0 inhomogeneity, the
interaction of the gradients with the more susceptible
material also leads to stronger net phase errors. Beyond
that, also flow velocity influences the amount of
Fig. 5 Flow deviation. Deviation of the assessed flow from reference flow over distance. Dark grey: range of equivalence 15%. Light grey: range
of equivalence 20%. Black dashed lines: 95% confidence interval
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Fig. 6 PC flow measurements in-vitro and in-vivo including a synthetic aortic valve model, two biological and one mechanical aortic valve prosthesis. a.
Flow measured in-vitro over the distance to the valve. b. Flow measured in-vivo over the distance to the valve. c In-vivo: Long axis view (Cine-imaging,
steady state free precession) showing the left ventricular outflow tract and the position of the aortic prosthesis (white arrow). d In-vivo: cine imaging of
the aortic valve location (left) and ascending aorta in the area of the suspected restored flow 26.4 mm distal to the aortic valve (right)
for each subject (columns)
Fig. 7 Background offset error detection. Measurements without flow. Deviation of estimated flow from reference flow over the entire distance in
all investigated objects. S2-12 = positions of image acquisition in flow phantom
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additionally accumulated phase and thus the extent of
flow miscalculation.
The strongest local magnetic field inhomogeneity and
maximum flow miscalculation were observed in prosthesis
II, with a maximum flow overestimation of around
150 ml/s in phantom, which is 53% deviant to the refer-
ence flow. In-vivo around 65 ml/s flow deviation was seen.
Our findings are related to the dedicated material of these
prostheses. The influence on the magnetic field depends on
the material. The induced local magnetic field distortions
have different impact on flow measurements [19, 28].
The impact of heart-valve-prostheses-related magnetic
field distortions depended on the distance of the meas-
urement slice to the level of the prostheses. Maximum
miscalculation is seen in the immediate proximity of the
prostheses. For the investigated prostheses, the flow
values converged in-vitro beyond a distance of about
20 mm and in-vivo about 30 mm distal to the level
of the prosthesis. We used a range of equivalence of
15% as a marker for significant deviation from refer-
ence flow. The background phase offset errors are
within this range; so we deduce a flow-related impact
of the metal components.
Although it could be shown that heart valve prostheses
are MR-safe up to 4.7 T, the magnetically induced elec-
tric currents can hamper the diagnostic performance
[29–31]. Both biological prostheses cause magnetic field
distortions and signal loss to various extents as seen in
Fig. 3. Prosthesis I is constructed onto a flexible, tender
stent, whereas prosthesis II comprises a semi-rigid,
three-base frame. The extent of magnetic field distortion
is related to the amount of metal. Another trial demon-
strated metal-stented aortic valve prostheses inducing
artefacts in CMR in terms of signal loss in the whole
left-ventricular outflow tract. In contrast, the stent-less
valve prostheses did not cause artefacts [32].
Among the research on heart valve prostheses, mag-
netic field distortions due to metallic compounds were
investigated in several studies, but flow-measurement-
related data are rare [33]. In our study, prosthesis II con-
sists of Elgiloy, an alloy recommended for biomedical
implants. As seen in Figs. 3 and 4, it evokes local mag-
netic field distortions. The mechanical prosthesis III,
composed mainly of pyrolythic carbon, was deemed to
be nonmagnetic, but showed magnetic field distortions.
The interaction between both mechanical and bio-
logical valve prostheses and magnetically induced elec-
tric currents has been demonstrated [34].
It has already been described that elements from stain-
less steel cause stronger artefacts than Nitinol-based prod-
ucts [19, 28]. Our in vitro results are supported by single
case examples, but have to be evaluated in a larger cohort.
Assessment of valvular prosthesis is of high impact in
clinical cardiology and CMR has an increasing influence.
Therefore these results could have an impact on applic-
ability of flow quantification in this patient group.
Strengths and limitations
Our study has the strength that we faced a potential obs-
tacle for clinical decision-making when using phase-
contrast techniques in patients with valve prostheses.
Our results are limited by the fact that our setting did
not include MR-independent flow quantification as a
reference. However, the setting has been validated previ-
ously [35] and the flow was kept constant to meet the
requirements for this study.
In our study, we investigated the behaviour of PC based
flow quantification using a flow-encoded and a flow-
compensated measurement. As other techniques exist -
such as the measurement with two flow-encoded measure-
ments - our findings cannot be generalized for all existing
flow measurement techniques in the same manner.
We have investigated three often-used prostheses. Our
findings cannot be directly extrapolated to all other
types of prosthesis. Especially the recommended distance
to achieve correct flow measurements needs careful
studies covering all types of prostheses. Further investi-
gation and analysis of all different valve prostheses have
to be conducted to address this need.
Conclusions
Our findings are of clinical interest as they may impact
clinical routine. Currently, specific distances are defined
for flow measurement of native valves and valve pros-
theses [36]. But the awareness of magnetic field
distortion-related flow miscalculations is limited. How-
ever, it can be concluded that flow measurements in the
proximity of stented valve prostheses are not reliable.
When performing PC based flow measurements in pa-
tients with heart valve replacement, one should be aware
of potential flow and volume miscalculation due to
prosthesis-related distortions of the magnetic field.
Further investigations regarding other available pros-
theses are needed, as clinical outcome after valve re-
placement is based on a patient-matched prosthesis,
which has to be determined by reliable measurements.
Further studies are needed to provide guidance for dif-
ferent field strengths and all types of prosthesis.
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